152 related articles for article (PubMed ID: 11312370)
21. Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.
Hamajima K; Hoshino Y; Xin KQ; Hayashi F; Tadokoro K; Okuda K
Clin Immunol; 2002 Jan; 102(1):12-8. PubMed ID: 11781062
[TBL] [Abstract][Full Text] [Related]
22. [Immunogenicity of a chimeric adenovirus type 5 vector with type 35 fiber containing HIV-1 gag in mice].
Liu XL; Yu SQ; Feng X; Wang XL; Liu HM; Zhang XM; Li HX; Zhou L; Li ZL; Zheng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):5-7. PubMed ID: 17429520
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.
Qiu JT; Song R; Dettenhofer M; Tian C; August T; Felber BK; Pavlakis GN; Yu XF
J Virol; 1999 Nov; 73(11):9145-52. PubMed ID: 10516021
[TBL] [Abstract][Full Text] [Related]
25. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
Li W; Li S; Hu Y; Tang B; Cui L; He W
Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
[TBL] [Abstract][Full Text] [Related]
26. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
27. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.
Wong SB; Siliciano RF
J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195
[TBL] [Abstract][Full Text] [Related]
28. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
29. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
[TBL] [Abstract][Full Text] [Related]
31. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice.
Gao F; Li Y; Decker JM; Peyerl FW; Bibollet-Ruche F; Rodenburg CM; Chen Y; Shaw DR; Allen S; Musonda R; Shaw GM; Zajac AJ; Letvin N; Hahn BH
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):817-23. PubMed ID: 14585212
[TBL] [Abstract][Full Text] [Related]
32. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.
Casimiro DR; Tang A; Perry HC; Long RS; Chen M; Heidecker GJ; Davies ME; Freed DC; Persaud NV; Dubey S; Smith JG; Havlir D; Richman D; Chastain MA; Simon AJ; Fu TM; Emini EA; Shiver JW
J Virol; 2002 Jan; 76(1):185-94. PubMed ID: 11739684
[TBL] [Abstract][Full Text] [Related]
33. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein].
Wang Q; Chen Y; Gao S; Jiang W; Song L; Huang W
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):773-80. PubMed ID: 21845844
[TBL] [Abstract][Full Text] [Related]
34. Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55(gag).
Bojak A; Wild J; Wolf H; Wagner R
Vaccine; 2002 May; 20(15):1980-4. PubMed ID: 11983258
[TBL] [Abstract][Full Text] [Related]
35. Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis.
Bojak A; Hammer D; Wolf H; Wagner R
Vaccine; 2002 May; 20(15):1975-9. PubMed ID: 11983257
[TBL] [Abstract][Full Text] [Related]
36. Immune response of mice infected with recombinant vaccinia viruses carrying the HIV gag gene.
Sugata F; Aoki N; Shioda T; Hayashi T; Shimada K; Mitamura K; Shibuta H
Microbiol Immunol; 1991; 35(10):849-61. PubMed ID: 1779889
[TBL] [Abstract][Full Text] [Related]
37. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
38. Induction of broad-based immune response against HIV-1 subtype C gag DNA vaccine in mice.
Chugh P; Seth P
Viral Immunol; 2004; 17(3):423-35. PubMed ID: 15357908
[TBL] [Abstract][Full Text] [Related]
39. Analysis of human lymphotropic T-cell virus type II-like particle production by recombinant baculovirus-infected insect cells.
Takahashi RH; Nagashima K; Kurata T; Takahashi H
Virology; 1999 Apr; 256(2):371-80. PubMed ID: 10191202
[TBL] [Abstract][Full Text] [Related]
40. Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma.
Dale CJ; Zhao A; Jones SL; Boyle DB; Ramshaw IA; Kent SJ
J Med Primatol; 2000 Aug; 29(3-4):240-7. PubMed ID: 11085586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]